These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 27465715)

  • 1. Cardiovascular, hemodynamic, neuroendocrine, and inflammatory markers in women with and without vasomotor symptoms.
    Gordon JL; Rubinow DR; Thurston RC; Paulson J; Schmidt PJ; Girdler SS
    Menopause; 2016 Nov; 23(11):1189-1198. PubMed ID: 27465715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships Between Vasomotor Symptoms and Mood in Midlife Urban Chinese Women: Observations in a Prospective Study.
    Tang R; Luo M; Li J; Peng Y; Wang Y; Liu B; Liu G; Wang Y; Lin S; Chen R
    J Clin Endocrinol Metab; 2020 Nov; 105(11):. PubMed ID: 32841324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perimenopausal vasomotor symptoms and the cortisol awakening response.
    Sauer T; Tottenham LS; Ethier A; Gordon JL
    Menopause; 2020 Nov; 27(11):1322-1327. PubMed ID: 33110049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasomotor symptoms and cardiovascular disease risk.
    Pines A
    Climacteric; 2011 Oct; 14(5):535-6. PubMed ID: 21848496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hot flushes and night sweats differ in associations with cardiovascular markers in healthy early postmenopausal women.
    Hitchcock CL; Elliott TG; Norman EG; Stajic V; Teede H; Prior JC
    Menopause; 2012 Nov; 19(11):1208-14. PubMed ID: 22781788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is an unfavourable cardiovascular risk profile a risk factor for vasomotor menopausal symptoms? Results of a population-based cohort study.
    van den Berg MJ; Herber-Gast GC; van der Schouw YT
    BJOG; 2015 Aug; 122(9):1252-8. PubMed ID: 25515605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Menopausal symptoms and risk factors for cardiovascular disease in postmenopause.
    Cagnacci A; Cannoletta M; Palma F; Zanin R; Xholli A; Volpe A
    Climacteric; 2012 Apr; 15(2):157-62. PubMed ID: 22141325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapse of vasomotor symptoms after discontinuation of the selective serotonin reuptake inhibitor escitalopram: results from the menopause strategies: finding lasting answers for symptoms and health research network.
    Joffe H; Guthrie KA; Larson J; Cohen LS; Carpenter JS; Lacroix AZ; Freeman EW
    Menopause; 2013 Mar; 20(3):261-8. PubMed ID: 23435022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K; Neuenschwander PF; Kurdowska AK
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond frequency: who is most bothered by vasomotor symptoms?
    Thurston RC; Bromberger JT; Joffe H; Avis NE; Hess R; Crandall CJ; Chang Y; Green R; Matthews KA
    Menopause; 2008; 15(5):841-7. PubMed ID: 18521049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the pathophysiology of vasomotor symptoms (hot flushes and night sweats) that occur in perimenopause, menopause, and postmenopause life stages.
    Deecher DC; Dorries K
    Arch Womens Ment Health; 2007; 10(6):247-57. PubMed ID: 18074100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasomotor menopausal symptoms and risk of cardiovascular disease: a pooled analysis of six prospective studies.
    Zhu D; Chung HF; Dobson AJ; Pandeya N; Anderson DJ; Kuh D; Hardy R; Brunner EJ; Avis NE; Gold EB; El Khoudary SR; Crawford SL; Mishra GD
    Am J Obstet Gynecol; 2020 Dec; 223(6):898.e1-898.e16. PubMed ID: 32585222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of menopausal vasomotor symptoms with increased bone turnover during the menopausal transition.
    Crandall CJ; Tseng CH; Crawford SL; Thurston RC; Gold EB; Johnston JM; Greendale GA
    J Bone Miner Res; 2011 Apr; 26(4):840-9. PubMed ID: 20878774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The menopausal hot flush: a review.
    Sturdee DW; Hunter MS; Maki PM; Gupta P; Sassarini J; Stevenson JC; Lumsden MA
    Climacteric; 2017 Aug; 20(4):296-305. PubMed ID: 28379074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of menopausal vasomotor symptoms over the menopause transition.
    Avis NE; Crawford SL; Greendale G; Bromberger JT; Everson-Rose SA; Gold EB; Hess R; Joffe H; Kravitz HM; Tepper PG; Thurston RC;
    JAMA Intern Med; 2015 Apr; 175(4):531-9. PubMed ID: 25686030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasomotor symptoms and risk of cardiovascular disease in peri- and postmenopausal women: A systematic review and meta-analysis.
    Armeni A; Anagnostis P; Armeni E; Mili N; Goulis D; Lambrinoudaki I
    Maturitas; 2023 May; 171():13-20. PubMed ID: 36907116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menopausal Vasomotor Symptoms and Risk of Incident Cardiovascular Disease Events in SWAN.
    Thurston RC; Aslanidou Vlachos HE; Derby CA; Jackson EA; Brooks MM; Matthews KA; Harlow S; Joffe H; El Khoudary SR
    J Am Heart Assoc; 2021 Feb; 10(3):e017416. PubMed ID: 33470142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasomotor symptoms in menopause: a biomarker of cardiovascular disease risk and other chronic diseases?
    Biglia N; Cagnacci A; Gambacciani M; Lello S; Maffei S; Nappi RE
    Climacteric; 2017 Aug; 20(4):306-312. PubMed ID: 28453310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are vasomotor symptoms associated with alterations in hemostatic and inflammatory markers? Findings from the Study of Women's Health Across the Nation.
    Thurston RC; El Khoudary SR; Sutton-Tyrrell K; Crandall CJ; Gold E; Sternfeld B; Selzer F; Matthews KA
    Menopause; 2011 Oct; 18(10):1044-51. PubMed ID: 21926929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipokines, adiposity, and vasomotor symptoms during the menopause transition: findings from the Study of Women's Health Across the Nation.
    Thurston RC; Chang Y; Mancuso P; Matthews KA
    Fertil Steril; 2013 Sep; 100(3):793-800. PubMed ID: 23755948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.